Theravance Biopharma Inc (TBPH)
Cash & Short-Term Investments
$387.66M
Quarterly · Period ending: · USD
TBPH Cash & Short-Term Investments
Latest reported$387.66Mperiod ending
Latest reported$387.66Mperiod ending
TBPH Quarterly Cash & Short-Term Investments ($0.00 → $387.66M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
TBPH cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 387,657,000 | |
| 394,666,000 | |
| 315,357,000 | |
| 329,680,000 | |
| 338,804,000 | |
| 130,855,000 | |
| 88,350,000 | |
| 91,361,000 | |
| 96,078,000 | |
| 99,975,000 | |
| 102,426,000 | |
| 134,003,000 | |
| 167,451,000 | |
| 241,263,000 | |
| 327,484,000 | |
| 486,832,000 | |
| 132,850,000 | |
| 147,516,000 | |
| 173,465,000 | |
| 216,213,000 | |
| 264,952,999 | |
| 209,968,000 | |
| 292,941,000 | |
| 358,347,000 | |
| 438,340,000 | |
| 487,031,000 | |
| 280,831,000 | |
| 319,681,000 | |
| 396,072,000 | |
| 434,058,000 | |
| 505,276,000 | |
| 300,409,000 | |
| 352,903,000 | |
| 418,531,000 | |
| 348,566,000 | |
| 335,001,000 | |
| 361,820,000 | |
| 392,768,000 | |
| 501,096,000 | |
| 230,482,000 | |
| 249,679,000 | |
| 179,876,000 | |
| 172,434,000 | |
| 195,970,000 | |
| 210,986,000 | |
| 236,236,000 | |
| 306,010,000 | |
| 350,355,000 | |
| 387,427,000 | |
| 833,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |